SAFETY
Clinical trials for SAFETY explained in plain language.
Never miss a new study
Get alerted when new SAFETY trials appear
Sign up with your email to follow new studies for SAFETY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Massive study tracks 12,000 people for COVID vaccine side effects
⭐️ VACCINE ⭐️ OngoingThis study is monitoring the safety of the already-approved Pfizer COVID-19 vaccine in real-world use in Korea. It will follow 12,000 people who receive the vaccine as part of their normal healthcare, tracking any side effects they report for 28 days after each dose. The goal is …
Matched conditions: SAFETY
Sponsor: Pfizer • Aim: ⭐️ VACCINE ⭐️
Last updated Apr 01, 2026 14:43 UTC
-
Cancer-Fighting cell therapy tested for tough lupus cases
Disease control TerminatedThis early-stage study is testing a new therapy called RD06-04, which uses a patient's own modified immune cells (CAR-T cells), for people with moderate to severe lupus. The main goals are to check if the treatment is safe, see how the body processes it, and find the best dose. U…
Matched conditions: SAFETY
Phase: NA • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC
-
Groundbreaking trial aims to protect moms and babies from mpox
Prevention OngoingThis study is testing the safety and immune response of the MVA-BN mpox vaccine in pregnant and recently delivered women in the Democratic Republic of the Congo, where mpox is a risk. It will enroll 359 women to receive two vaccine doses either during pregnancy or right after giv…
Matched conditions: SAFETY
Phase: PHASE3 • Sponsor: Jean-Pierre Van geertruyden • Aim: Prevention
Last updated Mar 30, 2026 14:28 UTC